FIELD: medicine.
SUBSTANCE: invention represents a combination containing VEGF Trap and 5-fluorouracil to be applied in treatment of neoplasms.
EFFECT: higher effectiveness of the combination ensured by therapeutic synergism of its components, and reduced toxicity.
4 cl, 1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTI-CANCER COMBINATIONS CONTAINING VEGF INHIBITOR AND IRINOTECAN | 2008 |
|
RU2471483C2 |
ANTITUMOR COMPOSITION CONTAINING TAXANE DERIVATIVES | 1993 |
|
RU2131250C1 |
COMBINATION CONTAINING COMBRETASTATIN AND CANCER AGENTS | 2006 |
|
RU2396952C2 |
ANTINEOPLASTIC COMPOSITIONS CONTAINING TAXANE DERIVATIVES | 2007 |
|
RU2414930C2 |
SYNERGIC METHODS AND COMPOSITIONS FOR CANCER TREATMENT | 2001 |
|
RU2264217C2 |
COMBINATION THERAPY WITH ANTICANCER ALKALOID | 2018 |
|
RU2767664C2 |
COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID | 2011 |
|
RU2605335C2 |
COMBINATION THERAPY WITH ANTITUMOR ALKALOID | 2018 |
|
RU2757373C2 |
COMBINATION THERAPY WITH ANTITUMOR ALKALOID | 2011 |
|
RU2743643C2 |
COMBINATIONS OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS AND METHODS OF USE | 2013 |
|
RU2671489C2 |
Authors
Dates
2010-03-20—Published
2005-12-02—Filed